DRAinh-A250
DRAinh-A250 is an orally active inhibitor of mouse and human SLC26A3 (DRA). DRAinh-A250 inhibits SLC26A3-mediated anion transport, blocks colonic fluid absorption, reduces luminal fluid alkalization in the distal colonic loops of mice, and alleviates Loperamide (HY-156131)-induced constipation in wild-type and cystic fibrosis mice. DRAinh-A250 can be used in the research of constipation and cystic fibrosis-related constipation.
For research use only. We do not sell to patients.
- CAS No.: 858747-13-4
- Formula: C20H17BrO5
- Molecular Weight:417.26
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HEK293 | IC50 |
0.25 μM
|
Inhibition of human SLC26A3-mediated Cl-/I- exchange in HEK cells using YFP halide sensor.
Inhibition of human SLC26A3-mediated Cl-/I- exchange in HEK cells using YFP halide sensor.
|
30046015 |
In Vitro
DRAinh-A250 (compound 4ba) (0.001-1 μM) potently inhibits slc26a3-mediated chloride/iodide exchange in Fischer rat thyroid cells expressing mouse slc26a3 and halide-sensitive yellow fluorescent protein, with an IC50 of 0.15 μM[1].
DRAinh-A250 (0.02-12.5 μM) potently inhibits mouse slc26a3-mediated Cl−/HCO3− exchange in FRT cells, with an IC50 of approximately 0.1 μM[2].
DRAinh-A250 (0.01-3 μM) inhibits Cl−/SCN− exchange mediated by mouse slc26a3 in FRT cells, with an IC50 of approximately 0.3 μM[2].
DRAinh-A250 (1 μM; 0-5 min for inhibition kinetics, 10 min for reversibility washout) rapidly inhibits mouse slc26a3-mediated Cl−/I− exchange in FRT-YFP-slc26a3 cells[2].
DRAinh-A250 (0.156-1.25 μM) potently inhibits human SLC26A3-mediated Cl−/I− exchange in HEK cells, with an IC50 of approximately 0.25 μM[2].
DRAinh-A250 (10 μM; 24 h) shows no cytotoxicity to T84 cells after 24-hour incubation[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:T84 cells
-
Concentration:10 μM
-
Incubation Time:24 h
-
Result:Did not cause toxicity in T84 cells.
Parmacokinetics
In Vivo
DRAinh-A250 (5 mg/kg; p.o.; single dose) partially reverses loperamide-induced constipation in wild-type mice and significantly alleviates loperamide-induced constipation in cystic fibrosis mice[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:wild-type; cystic fibrosis mice with loss of functional CFTR[2]
-
Dosage:5 mg/kg
-
Administration:p.o.; single dose
-
Result:Partially prevented Loperamide-induced reductions in stool weight, pellet number, and stool water content in wild-type mice.
Significantly increased stool weight, pellet number, and stool water content compared to Loperamide-only treated cystic fibrosis mice, reducing Loperamide-induced constipation.
Demonstrated fully reversible anticonstipation effect, with Loperamide-induced constipation remaining intact when administered 24 hours after treatment.
Chemical Information
-
CAS No. 858747-13-4
-
Molecular Weight 417.26
-
Formula C20H17BrO5
-
SMILES
O=C1OC2=C(C=CC(OCC=3C=CC=C(Br)C3)=C2C)C(=C1CC(=O)O)C
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Fibrosis/Collagen Morphometry
Fibrosis and collagen morphometry is based on the quantitative visualization of fibrillar collagen deposition in tissue sections using histochemical stains such as Sirius Red (Picrosirius Red) or Masson's trichrome, followed by image-based or polarization-enhanced analysis to estimate collagen proportional area as a surrogate of extracellular matrix accumulation during fibrotic remodeling. Sirius Red combined with polarized light microscopy enhances detection of collagen fibers due to birefringence properties, enabling more specific visualization of collagen type I and III fibrils compared to conventional bright-field histology, while whole-section or region-restricted digital morphometry reduces field-selection bias in fibrosis assessment. Alternative quantitative approaches include second harmonic generation (SHG) and two-photon excited fluorescence microscopy, which enable label-free detection of fibrillar collagen and have been validated against histological staining and biochemica
-
Collagen: Sirius Red Staining
Sirius Red or picrosirius red staining is a histochemical method for visualizing collagen-rich extracellular matrix in tissue sections, and collagen fibers are detected as red-stained structures under bright-field microscopy with enhanced birefringence under polarized light. Picrosirius red is useful for assessing total collagen organization, distribution, and fibrosis burden, but polarized color should not be interpreted as a definitive collagen type I versus type III readout because color is affected by fiber orientation, thickness, and packing.
-
Connective Tissue: Masson's Trichrome/Collagen Trichrome Staining
Masson’s Trichrome (collagen/trichrome staining) is a histological technique that differentially stains tissue compartments using sequential acidic dyes to distinguish collagen from muscle and cytoplasmic components based on dye affinity and tissue permeability differences, enabling visualization of fibrosis and connective tissue architecture in histological sections. The classical formulation typically uses Weigert's iron hematoxylin for nuclear staining, Biebrich scarlet-acid fuchsin for cytoplasm and muscle, and aniline blue (or light green variants) for collagen, producing a characteristic blue/green collagen signal contrasted against red cytoplasm and dark nuclei. The staining principle relies on selective displacement of smaller dye molecules by larger anionic dyes in collagen-rich regions under controlled acidified conditions, which enhances collagen-specific dye retention. This property makes the method widely used for fibrosis assessment in organs such as heart, liver, lung, a
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)